Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Reviews in the Neurosciences|July 7, 2023
The brain serotonin system in autismAlexander Ya Rodnyy, Elena M Kondaurova, Anton S Tsybko, et al.Journal of Personalized Medicine|December 29, 2022
Markers for the Prediction of Probably Sarcopenia in Middle-Aged IndividualsYulia G Samoilova, Mariia V Matveeva, Ekaterina A Khoroshunova, et al.International Journal of Molecular Sciences|July 13, 2024
A Novel Multiplex LAMP Assay for the Detection of Respiratory Human AdenovirusesMaksim A Koryukov, Igor P Oscorbin, Lidiya M Novikova, et al.International Journal of Molecular Sciences|July 12, 2025
Phosphorus-Derived Isatin Hydrazones: Synthesis, Structure, Thromboelastography, Antiplatelet, and Anticoagulation Activity EvaluationAleksandr V Samorodov, Wang Yi, Dmitry A Kudlay, et al.Diagnostics (Basel, Switzerland)|July 13, 2024
Vitamin D Metabolism Parameters and Cytokine Profile in COVID-19 Patients with Bolus Cholecalciferol SupplementationTatiana L Karonova, Arina A Mikhaylova, Ksenia A Golovatyuk, et al.Life (Basel, Switzerland)|August 28, 2025
Causal Association of Free Triiodothyronine Level with Ischemic Stroke Outcome: A Mendelian Randomization StudyDmitry A Filimonov, Vitaly V Morozov, Roman V Ishchenko, et al.International Journal of Molecular Sciences|January 28, 2026
Approach to Design of Potent RNA Interference-Based Preparations Against Hepatocellular Carcinoma-Related GenesPetr V Chernov, Vladimir N Ivanov, Nikolai A Dmitriev, et al.Molecules (Basel, Switzerland)|December 31, 2025
Design and Biological Evaluation of Monoterpene-Conjugated (S)-2-Ethoxy-3-(4-(4-hydroxyphenethoxy)phenyl)propanoic Acids as New Dual PPARα/γ AgonistsSergey A Borisov, Mikhail E Blokhin, Yulia V Meshkova, et al.Annals of Hematology|August 16, 2021
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumabAlexander D Kulagin, Vadim V Ptushkin, Elena A Lukina, et al.Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and FlareEkaterina I Alexeeva, Irina T Tsulukiya, Tatyana M Dvoryakovskaya, et al.Pageof 2